Expression of BC047440 protein in hepatocellular carcinoma and its relationship to prognosis

Chinese Journal of Cancer

Volumn 29, Issue 11, 2010, Pages 931-936

  Zheng, Lu ^a   Liang, Ping ^a   Li, Jing ^a   Huang, Xiao Bing ^a   Wang, Wei Wei ^a   Wang, Liang ^a   Feng, Huan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Liver neoplasm; Polyclonal antibody; Prognosis

Indexed keywords

BC047440 PROTEIN; POLYCLONAL ANTIBODY; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LIVER CELL CARCINOMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RABBIT; SURVIVAL RATE; WESTERN BLOTTING;

EID: 79955869226     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10272     Document Type: Article

References (20)

1. Bosch FX, Ribes J, Cléries R, et al. Epidemiology of hepatocellular carcinoma [J]. Clin Liver Dis, 2005, 9(2): 191-211.
2. Vander-Borght S, Komuta M, Libbrecht L, et al. Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin [J]. Liver Int, 2008, 28(10): 1370-1380.
3. Teufel A, Staib F, Kanzler S, et al. Genetics of hepatocellular carcinoma [J]. World J Gastroenterol, 2007, 13(16): 2271-2282.
4. Li J, Han BL, Huang GJ, et al. Screening and identification for cDNA of differentially expressed genes in human primary hepatocellular carcinoma [J]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2003, 20(1): 49-52. [in Chinese]
5. Zhao HZ, Li J, Liang P, et al. Molecular cloning and identification of a novel gene and its relationship to hepatocellular carcinoma [J]. Zhonghua Gan Zang Bing Za Zhi, 2005, 13(7): 483-487. [in Chinese]
6. Zheng L, Li J, Yang TH, et al. Expression of BC047440 gene in human hepatocellular carcinoma tissues and its significance [J]. Chin J General Surg, 2006, 15(8): 582-585. [in Chinese]
7. Zhou JB, Li J, Liang P, et al. Primary study of the function of a novel gene BC047440 highly expressed in human hepatocellular carcinoma [J]. Chin J Exp Surg, 2006, 23(3): 288-290. [in Chinese]
8. Zheng L, Li J, Liang P, et al. Prokaryotic expression, purification of BC047440 protein relevant to hepatocellular carcinoma [J]. Chin J Hepatobiliary Surg, 2009, 15(12): 934-937. [in Chinese]
9. Kothari H, Kumar P, Singh N. Prokaryotic expression, purification, and polyclonal antibody production against a novel drug resistance gene of leishmania donovani clinical isolate [J]. Protein Expr Purif, 2006, 45(1): 15-21.
10. Qin G, Su J, Ning Y, et al. p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China [J]. Cancer Lett, 1997, 121(2): 203-210.
11. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis [J]. Cancer Lett, 2007, 252(2): 157-170.
12. Kuznecovs S, Kuznecovs I. 0L-048 P-glycoprotein regulation in Hep3B cells by polyprenol could decrease the risk of hepatocarcinogenesis in HBV [J]. Int J Infect Dis, 2009, 13: S45.
13. Hwang YH, Choi JY, Kim S, et al. Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma [J]. Hepatol Res, 2004, 29(2): 113-121.
14. Marrero JA, Feng Z, Wang Y, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma [J]. Gastroenterology, 2009, 137(1): 110-118.
15. Abelev GI, Eraiser TL. Cellular aspects of alpha-fetoprotein reexpression in tumors [J]. Semin Cancer Biol, 1999, 9(2): 95-107.
16. Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications [J]. Clin Chim Acta, 2008, 395(1-2): 19-26.
17. Liu SC, Li J, Huang XB, et al. siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell [J]. Acta Academiae Medicine Militaris Tertiae, 2007, 29(23): 2207-2211. [in Chinese]
18. Faivre J, Forman D, Esteve J, et al. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe [J]. Eur J Cancer, 1998, 34(14): 2184-2190.
19. Chen PH, Lin YC, Tu HP, et al. Important prognostic factors for the long-term survival of subjects with primary liver cancer in Taiwan: A hyperendemic area [J]. Eur J Cancer, 2007, 43(6): 1076-1084.
20. Pignata S, Gallo C, Daniele B, et al. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly: a study of the Cancer of the Liver Italian Program (CLIP) [J]. Crit Rev Oncol Hemat, 2006, 59(3): 243-249.